CAT

379.24

+0.59%↑

RTX

118.81

-1.94%↓

UNP

232.45

+0.08%↑

HON

209.17

+1.56%↑

ETN

334.84

+0.69%↑

CAT

379.24

+0.59%↑

RTX

118.81

-1.94%↓

UNP

232.45

+0.08%↑

HON

209.17

+1.56%↑

ETN

334.84

+0.69%↑

CAT

379.24

+0.59%↑

RTX

118.81

-1.94%↓

UNP

232.45

+0.08%↑

HON

209.17

+1.56%↑

ETN

334.84

+0.69%↑

CAT

379.24

+0.59%↑

RTX

118.81

-1.94%↓

UNP

232.45

+0.08%↑

HON

209.17

+1.56%↑

ETN

334.84

+0.69%↑

CAT

379.24

+0.59%↑

RTX

118.81

-1.94%↓

UNP

232.45

+0.08%↑

HON

209.17

+1.56%↑

ETN

334.84

+0.69%↑

Inicio・Lista de Acciones・Enovis Corp

Enovis Corp

Cerrado

Sector

42.4 2.32

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

41.31

Máximo

43.34

Métricas clave
By Trading Economics
Ingresos	53M -19M
Ventas	9.2M 525M
BPA	0.62
Margen de beneficio	-3.549
Empleados	6,550
EBITDA	41M 55M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+55.42 upside

Dividendos
By Dow Jones
Próximas Ganancias	6 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	19M 2.3B
Apertura anterior	40.08
Cierre anterior	42.4

Noticias sobre sentimiento de mercado

By Acuity

50%

229 / 472 Clasificación en Industrials

Enovis Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 nov 2024, 22:50 UTC

Acciones populares

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1 nov 2024, 22:43 UTC

Principales Movimientos del Mercado

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1 nov 2024, 22:13 UTC

Principales Movimientos del Mercado

Chewy Up 5% on S&P MidCap 400 Inclusion

1 nov 2024, 21:39 UTC

Ganancias

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

1 nov 2024, 22:51 UTC

Ganancias

Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ

1 nov 2024, 22:00 UTC

Principales Noticias

Ganancias

Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ

1 nov 2024, 21:29 UTC

Principales Noticias

Ganancias

Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update

1 nov 2024, 21:24 UTC

Ganancias

Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane

1 nov 2024, 20:57 UTC

Ganancias

BYD's Sales Hit a Record. It's Neck and Neck in EV Race With Tesla. -- Barrons.com

1 nov 2024, 20:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

1 nov 2024, 20:50 UTC

Charlas de Mercado

Ganancias

Auto & Transport Roundup: Market Talk

1 nov 2024, 20:48 UTC

Principales Noticias

Ganancias

Stocks Wrap Up Volatile Week With Gains -- WSJ

1 nov 2024, 20:44 UTC

Ganancias

AI Spending Dominated Big Tech Earnings. Why These 2 Stocks Got a Pass From Investors. -- Barrons.com

1 nov 2024, 20:10 UTC

Principales Noticias

Nasdaq, Dow Rebound After Jobs Report Disappoints -- WSJ

1 nov 2024, 19:47 UTC

Ganancias

Apple's Earnings Confirmed 1 Thing: Nobody Knows When a Major Upgrade Cycle Is Coming -- Barrons.com

1 nov 2024, 19:43 UTC

Charlas de Mercado

U.S. Natural Gas Ends Week Lower Awaiting Winter Weather -- Market Talk

1 nov 2024, 19:32 UTC

Charlas de Mercado

Oil Futures End Week With Losses -- Market Talk

1 nov 2024, 19:14 UTC

Principales Noticias

U.S. Job Growth Gradually Slowing Beyond Storm, Strike Disruptions - Analysis

1 nov 2024, 18:41 UTC

Charlas de Mercado

Mexican Manufacturing PMIs Point to Sluggish October -- Market Talk

1 nov 2024, 18:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 nov 2024, 18:35 UTC

Charlas de Mercado

November Fed Meeting Seen as Routine -- Market Talk

1 nov 2024, 18:33 UTC

Ganancias

These Stocks Are Moving the Most Today: Apple, Amazon, Intel, Boeing, Super Micro, Exxon, and More -- Barrons.com

1 nov 2024, 18:31 UTC

Charlas de Mercado

SPDR Gold Falls Late in Trading -- Market Talk

1 nov 2024, 18:06 UTC

Ganancias

Amazon's Big Spending Is Getting a Pass From Investors. Here's Why. -- Barrons.com

1 nov 2024, 18:02 UTC

Principales Noticias

U.S. Added Just 12,000 Jobs in October; Dow, Nasdaq Rally After Selloff -- WSJ

1 nov 2024, 17:46 UTC

Charlas de Mercado

Ganancias

Uber on Right Path to Achieve Mid-Term Targets -- Market Talk

1 nov 2024, 17:45 UTC

Principales Noticias

U.S. Added 12,000 Jobs in October as Storms Sidelined Workers -- 6th Update

1 nov 2024, 17:44 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

1 nov 2024, 17:44 UTC

Charlas de Mercado

McDonald's Can Recover From Short-Term Struggles, Analysts Say -- Market Talk

1 nov 2024, 17:33 UTC

Charlas de Mercado

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

Comparación entre iguales

Cambio de precio

Enovis Corp Esperado

Precio Objetivo

By TipRanks

55.42% repunte

Estimación a 12 meses

Media 64.14 USD 55.42%

Máximo 75 USD

Mínimo 50 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Enovis Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Enovis Corp Dist en los últimos 3 meses.

Sentimiento

By Acuity

229 / 472 Clasificación en

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

Acerca de Enovis Corp

Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.